Wenzel Spine Announces the Launch of the S-LIF Procedure: Prioritizing Surgical Minimalism for Outpatient Spine Fusion

Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today announced the launch of the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion using the VariLift®-LX device, the only stand-alone expandable posterior lumbar interbody fusion device that is FDA-cleared for 1 or 2 level fusion.

In addition, Wenzel Spine recently held its first S-LIF Training Lab in Austin, Texas in August to give surgeons the opportunity to gain hands-on experience with this practice-differentiating procedure and explore new ways they can prioritize surgical minimalism for appropriate patients in their practice.

William Wilson, newly appointed CEO of Wenzel Spine, noted, “Surgeons came to the lab with the question, ‘If I’m doing a least-invasive surgery and not incorporating screws and rods, how can I have confidence knowing that this technology will lead to strong, stable fusion for my patients?’ It was validating to watch them leave feeling excited, saying, ‘I can’t wait to start using this more and more in my practice.’”

Participating in the training was Ahmer Ghori, M.D., an orthopedic surgeon in Fort Wayne, Indiana, who has done 50+ “Awake Fusion” procedures with Wenzel’s VariLift. He stated, “Increasingly, surgeons are asking, ‘What is the least invasive spine surgery that I can do for this patient?’ The VariLift device has allowed me to operate on some patients on an outpatient basis, usually using a local spinal anesthetic; and with the correct anesthesia plan, they have reasonable pain control to where they can go home and return to their lives sooner than if they had undergone a much bigger operation.”

But oftentimes, surgeons think that using a stand-alone device might lead to subsidence, or question whether the simplified construct will eventually fail.

Not so, says Michael Weiss, M.D., an orthopedic surgeon in Boca Raton, Florida. “When you insert the device, screw it into place, expand it, and hear the mechanism pulling those bones apart, you see and feel the results. They don’t subside. They give you excellent bone graft abilities. And after you’ve done a few of these, you then get the confidence that, ‘I don’t need all that posterior fixation,’ because the anterior column, when that’s solid, it’s solid and your spine is stable. So, if you are worried that this is not enough, you can allay those fears, because it is.”

Another Surgeon Faculty member, Adam Kremer, M.D., a neurosurgeon in Bay City, Michigan, agrees saying, “Using this device to restore height and alignment and stabilize the weak joint, I feel very strongly that I’m fixing the root cause, and having an outpatient lumbar fusion surgery option really gives patients hope.”

As spinal fusion procedures continue to migrate to the ASC and outpatient environments, the S-LIF Procedure is positioned as an ideal complement for the right patient. And with more research and validation emerging around the use of local spinal anesthetic for fusion procedures, a stand-alone option with a single implant and a single incision takes the fear out of the word “fusion” for patients.

Alex West, M.D., a neurosurgeon in Houston, Texas, added, “People hear the word ‘fusion’ and they get very nervous. With VariLift, my patients are going home in two hours in many cases. One patient called me the following morning and said, ‘Something is wrong because I don’t have any pain.’ Being able to use a least-invasive device with a zero-profile construct that expands in situ makes a world of difference to patient and surgeon alike.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version